Provided by Tiger Fintech (Singapore) Pte. Ltd.

Compass Therapeutics, Inc.

2.60
-0.0900-3.35%
Volume:734.31K
Turnover:1.91M
Market Cap:359.53M
PE:-6.49
High:2.69
Open:2.68
Low:2.53
Close:2.69
Loading ...

Compass Therapeutics Initiated at Overweight by Piper Sandler

Dow Jones
·
19 Feb

Buy Rating for Compass Therapeutics Driven by Promising Tovecimig Results and Strategic Pipeline

TIPRANKS
·
19 Feb

Compass Therapeutics Inc. : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $12

THOMSON REUTERS
·
19 Feb

Optimistic Buy Rating for Compass Therapeutics Due to Promising CTX-009 Trial Results and Market Potential

TIPRANKS
·
11 Feb

Compass Therapeutics price target raised to $8 from $7 at Jefferies

TIPRANKS
·
11 Feb

Compass Therapeutics Inc. : Jefferies Raises Target Price to $8 From $7

THOMSON REUTERS
·
10 Feb

Dell Stock Set to Benefit From AI and Cloud Applications, Analyst Says. Plus, Twilio, Tradeweb, and More. -- Barrons.com

Dow Jones
·
11 Jan

Compass Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Jan

Compass Therapeutics: Strategic Advancements and Promising Pipeline Justify Buy Rating

TIPRANKS
·
09 Jan

Compass Therapeutics: Strong Growth Potential Bolstered by Upcoming Milestones and Strategic Focus

TIPRANKS
·
08 Jan

BRIEF-Compass Therapeutics Provides Corporate Update And Announces Advancement Of A New Drug Candidate

Reuters
·
08 Jan

Compass Therapeutics Inc.: Expect to Submit an Ind by End of 2025 for Ctx-10726

THOMSON REUTERS
·
08 Jan

Compass Therapeutics Inc. - Top-Line Phase 2/3 Data for Tovecimig Expected End of Q1 2025

THOMSON REUTERS
·
08 Jan

Compass Therapeutics Inc. - Two Phase 2 Biomarker Trials Expected to Initiate Mid-2025

THOMSON REUTERS
·
08 Jan

Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug Candidate

THOMSON REUTERS
·
08 Jan

Compass Therapeutics: Estimates $127 Mln in Cash & Marketable Securities at Ye 2024, Which Is Expected to Provide Cash Runway Into Q1 2027

THOMSON REUTERS
·
08 Jan

Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug Candidate

GlobeNewswire
·
08 Jan

US Penny Stocks To Watch In January 2025

Simply Wall St.
·
08 Jan

Compass Therapeutics Names Barry Shin CFO

MT Newswires Live
·
10 Dec 2024

Is Compass Therapeutics, Inc. (CMPX) Stock Outpacing Its Medical Peers This Year?

Zacks
·
10 Dec 2024